Connect with us

General News

Marijuana Awareness In The U.S Pet Industry

Published

on

Marijuana infused pet food

It is fascinating to know that a considerable percentage of medical marijuana consumers are animals. There is an increasing amount of information that states various health advantages of marijuana for pets. People having pets are mostly aware of these benefits and also treatments relying on the substance.

However, there is no proper guidance or a platform to instill in them the knowledge and techniques to treat their pets with medical marijuana. Luckily, platforms like Cannvas MedTech are arising to deal with this issue. They have an aim to provide unbiased and evidence-based knowledge of marijuana efficiency in treating pets suffering from a disease.

This leads to open passage for all leading brands in the pet industry to sit at a table and negotiate about the underlying problem. Experts will be able to sort out ways to tackle the lack of awareness among U.S. citizens. Also, it gives room for medical researchers to look into the potential benefits of marijuana for animals having certain conditions.

However, a considerable number of pet owners are already adapting to this substance, and they report positive effects on their pets. Just like humans feel better after using medical marijuana against seizures, pain, and other conditions, pets also show an alleviation in the symptoms. People use a specific compound in marijuana that does not cause intoxication in their pets. The unique chemical, CBD tends to be highly effective in addressing the situation at hand and provide quick results.

The company lays a huge impact on the research network in the U.S

The company has its roots in Canada, where medical researchers have already begun to look deep into the matter. With its more expanding policy, it is now looking forward to initiating the same thirst for awareness about the marijuana effectiveness in animals among the U.S researchers. This will tend to open up more pathways and end up the stigma of substance use in not only humans but also animals.

It is a great deal that currently the U.S. Food and Drug Administration has placed no reservations on the use of marijuana as for medical purposes in pets. In addition to that, people using marijuana to treat their animals are significantly finding positive results.

It will be easy on the pockets

It will not be only beneficial for the pets, but it also saves a significant amount of money of pet owners. According to the American Pet Products Association report in 2016, U.S citizens have spent more than thirty billion dollars on the clinical expenses and veterinary care of their pets. On more awareness and guidance, this can be saved to a large extent.

Experts have already started working on targeting this issue. They will incorporate Cannvas Data with total revenue data coming up from leading pet centers, veterinary clinics in the U.S through a geo-targeted advertisement plan to extract user behavior. They will use the data keeping in mind the privacy of people, thus keeping it anonymous. Experts will make a report on the pet industry trend under the marijuana sector.

They conducted an analytical study in Washington, California, Oregon and Colorado. In 2017, people from these states spent about 7 million dollars on marijuana products for their pets.

Charlotte’s Web and CBD oil products for animals

As in the hemp oil industry, Charlotte’s Web is the leading company. It launched its first product for pet dogs in 2016. A few days ago, it introduced a whole new range of products for dogs with a diverse set of options.
The American Veterinary Medical Association has not yet put any comment relating to the emerging trend. However, the pet industry is looking quite exhilarated towards the promising future of medical marijuana in veterinary care.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

General News

Global Alliance for Cannabis Commerce announces GACC Certified™ testing

Published

on

The Global Alliance for Cannabis Commerce (GACC) provides policymakers and legislators with the guidance necessary to take the nascent cannabis industry from the gray market into a global provider of medical and adult-use cannabis products.

Recently, the Company announced the launch of a nationwide, voluntary industry certification standard for safety and purity in cannabis product testing. The aim of this program is to provide licensed sellers and consumer confidence that the legal products are safe and they meet the purity standards. By the end of 2020, this program will be available to all state-licensed cannabis operations.

The Executive Director at GACC, Randal John Meyer says that with the current laws it is impossible to make sure that there are uniform standards for purity. Furthermore, GACC President Rezwan Khan added, ”GACC wants to establish a means by which consumers can have confidence in the products they buy and to provide the industry the tools to give this assurance.”

GACC and the member of the companies believe in establishing standards for safety and purity, and in creating a serious and effective testing program. Nominations for membership on the Standards Committee (terms are two years) will be open to the public beginning on Thursday, December 5, 2019, and closing on January 30, 2020.

The Board of GACC will determine the initial composition. Future members will include public nominations and will be determined by the GACCAST Standards Committee and reviewed by the GACC Board of Directors. It is expected that the GACCAST Standards Committee will take approximately nine months to establish the initial standards and protocols so that implementation can begin in 2020.

Brands such as Raw Garden, DNA Genetics, Crockett Family Farms, Urbn Leaf, La Familia, and Team Elite Genetics, and all derivative cannabis products from DNA Genetics’ and Crockett Family Farms’ genetic have pledged to support the development of the standards setting protocol and to adopt and implement it as well when it is effective.

To accommodate the entire legal cannabis industry’s access to this program, GACC will be creating a membership class, the Standard Membership, which involves minimal costs for participation, and that will provide access to the GACC Certified™ Program. GACC is also planning to arrange for testing discounts for members who use the GACC network of laboratories. The GACC President Rezwan Khan added, “Our goal is to ensure this program isn’t cost-prohibitive for any cannabis companies of any size.”

Solo sciences will be offering GACC members a substantial discount on anti-counterfeiting, instant product recall solo*CODE™ technology as they have previously partnered with GACC to ensure that medical patients and adult consumers do not unwittingly purchase counterfeit or illicit vape products.

On this account, the Executive Director of GACC added, “The combination of the voluntary GACC Certified™ consumer safety standard, particularly when combined with members’ access to substantially discounted solo*CODE™ anticounterfeiting technology, allows GACC members to provide their consumers with the confidence they need that anywhere in the United States they legally purchase a participating cannabis product, our blue leaf means it’s safe and genuine.”

Continue Reading

General News

Pasha Brand’s Board Restructuring, announces resignations

Published

on

Pasha Brands Ltd. is one of North America’s largest network and aggregator of craft cannabis. Recently, the Company announced the following resignations: Scott WaltersRosy Mondin and Hugo Alves as directors of the Company. Pasha Brand thanked them for their contributions, time, and efforts.

The Executive Chairman, Patrick Brauckmann stated, ”I’m grateful Scott, Rosy and Hugo shared my vision and were able to contribute to our unique offering. Their resignations will not diminish our resolve to see this project completed, as thousands of cannabis professionals wait in line to re-enter the industry they created.”
However, the resignations are effective immediately.

The Company is now working on establishing a new working board. The idea behind a new board is to solely include people who invested in the brand and its future. The Company’s vision includes giving opportunities for small farmers, legacy brands, the brands excluded by the government, and the founders of Canada’s original cannabis industry. This will help the companies to enter the business world through Pasha’s craft aggregation platform.

Pasha Brand as a Company has proven its capabilities in cannabis cultivation, genetic research and development, product processing, and retail. This makes the Company uniquely positioned in the new legal cannabis market through its network of hundreds of craft cannabis suppliers. Given the opportunity, the brand also plans on refreshing the ranks and reposition the key personnel to reflect the Company’s goal of having Grizzlers™ and Roll Model™ pre-rolls in the market in early 2020.

The Company has many accomplishments under its brand name. Pasha Brand has acquired 8 pre-legalization brands. It established BC Craft Supply Co, which is a solution provider to the micro cultivation community is Canada. It acquired Medcann Health Products Ltd. The Medcann Health Company is a  Health Canada licensed cultivator and processor operating out of a 10,000 square foot facility on Vancouver Island. Another one of the acquired brands is Royal Green Acres Ltd., which is a late stage licensed producer applicant under the ACMPR. The Company established a proprietory platform bringing quality assurance to the craft industry by the name of Craft Labs™.

The Pasha Brand’s common shares trade on the CSE under the symbol “CRFT” and on the FSE under the symbol “ZZD”. Commenting on these changed, the Executive Chairman, Patrick Brauckmann mentioned that he wants a Company that works on the principle of quality and meaning. The Company recruited a strong group of cannabis professionals, brokers and operators, many of who played a part in creating Canada’s original cannabis industry to continue living up to its standards.

Continue Reading

Cannabis

HempMeds® announces partnership with Sezzle, Offers New Payment Solution

Published

on

Medical Marijuana, Inc, the first company to receive historic import permits for CBD products from the governments of BrazilMexicoArgentina, and Paraguay has recently announced a partnership of its subsidiary HempMeds with Sezzel, a leading alternative digital payment platform.

Located in U.S, the first ever publicly traded cannabis company Medical Marijuana inc. has also recently launched a new line of cannabis-derived nutraceutical products, brands and supply chain. As its subsidiary, HempMeds is a corporate portfolio company which is also the Company’s master distributor and contracted marketing company, handling sales and distribution.

Sezzle, a leading alternative digital payment platform offers customers cutting-edge payment alternatives. HempMeds® customers can choose Sezzle at checkout to delay full payment for their items, at zero percent interest. Consumers receive their items right away and Sezzle pays merchant upfront and assumes all repayment risk. It requires a 25 percent down payment at the time of purchase and the remaining balance is automatically scheduled as three equal-installment payments to be paid every two weeks.

President Todd Morrow of HempMeds said that their aim is to provide better services so everyone with a tight budget can afford the benefits. Sezzle offers a “buy-now, pay-later” service that does not require shoppers to enter into a traditional loan or pay any upfront fees or interest. Sezzle is certified up to PCI DSS Level 1 as a Service Provider. He further stated, “Partnering with Sezzle means that we can provide our customers with an easy way to lift some of the financial burden during this expensive time of year.”

HempMeds® was the first company to ever bring hemp-based cannabidiol (CBD) oil products to market in the U.S. and was also the first to make CBD products available in bulk for U.S. consumers. It was also the first-ever company to receive historic federal government import approvals for its CBD products in the nations, as well as the first to have its CBD products listed in the Prescribers’ Digital Reference and one of the first to be certified by the U.S. Hemp Authority.

Medical Marijuana, Inc. CEO Dr. Stuart Titus mentioned, “With the number of new consumers becoming interested in purchasing CBD, we believe that Sezzle is a great opportunity to make our CBD products more accessible to people of all socioeconomic backgrounds.” The number of people searching for e-commerce outlets to purchase CBD has increased every year since 2017. Researchers found that online search volume for CBD in the U.S. increased 160.4 percent in 2018 compared with 2017 and is expected to increase by 117.7 percent in 2019 compared to 2018.

Continue Reading

Trending